![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print May 8, 2002
Biochemistry, Kansas State University, Manhattan, KS 66506
Corresponding Author: zolkiea{at}ksu.edu
ADAM12 has been implicated in cell-cell interactions in myogenesis and cancer, but the structure of the mature form of ADAM12 is not known and its localization to the cell surface has been questioned. In this report, we show that the full length ADAM12 is N-glycosylated in the endoplasmic reticulum (ER) and proteolytically processed in the trans-Golgi to a ~90-kDa form. The ~90-kDa form, which lacks the prodomain, is the predominant form present at the cell surface. Replacement of Leu73 in the putativen
J. Biol. Chem, 10.1074/jbc.M110814200
Submitted on November 12, 2001
Revised on May 2, 2002
Accepted on May 8, 2002
Intracellular processing of metalloprotease disintegrin ADAM12
-helical region in the prodomain with a proline results in retention of ADAM12 in the ER and a complete lack of its processing. Deletion of the entire pro- and metalloprotease domains, however, does not affect the processing and trafficking of ADAM12. In contrast, replacement of the cytoplasmic domain of ADAM12 with that of ADAM9 or adding the c-myc tag at the C-terminus leads to a significant increase of transport of the protein to the cell surface. These results suggest that the cytoplasmic domain of ADAM12 plays an important role in regulating ADAM12 exit from the ER. We conclude that a properly folded mouse ADAM12, after passing a rate-limiting step of exit from the ER, is processed in the secretory pathway and reaches the cell surface, where it can mediate adhesion-mediated signaling.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
K. Bourd-Boittin, H. Le Pabic, D. Bonnier, A. L'Helgoualc'h, and N. Theret RACK1, a New ADAM12 Interacting Protein: CONTRIBUTION TO LIVER FIBROGENESIS J. Biol. Chem., September 19, 2008; 283(38): 26000 - 26009. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Dyczynska, D. Sun, H. Yi, A. Sehara-Fujisawa, C. P. Blobel, and A. Zolkiewska Proteolytic Processing of Delta-like 1 by ADAM Proteases J. Biol. Chem., January 5, 2007; 282(1): 436 - 444. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-H. Koo, J.-M. Longpre, R. P. T. Somerville, J. P. Alexander, R. Leduc, and S. S. Apte Cell-surface Processing of Pro-ADAMTS9 by Furin J. Biol. Chem., May 5, 2006; 281(18): 12485 - 12494. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. M. Wewer, M. Morgelin, P. Holck, J. Jacobsen, M. C. Lydolph, A. H. Johnsen, M. Kveiborg, and R. Albrechtsen ADAM12 Is a Four-leafed Clover: THE EXCISED PRODOMAIN REMAINS BOUND TO THE MATURE ENZYME J. Biol. Chem., April 7, 2006; 281(14): 9418 - 9422. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Huang, L. C. Bridges, and J. M. White Selective Modulation of Integrin-mediated Cell Migration by Distinct ADAM Family Members Mol. Biol. Cell, October 1, 2005; 16(10): 4982 - 4991. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lafuste, C. Sonnet, B. Chazaud, P. A. Dreyfus, R. K. Gherardi, U. M. Wewer, and F.-J. Authier ADAM12 and {alpha}9{beta}1 Integrin Are Instrumental in Human Myogenic Cell Differentiation Mol. Biol. Cell, February 1, 2005; 16(2): 861 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sapir, E. Assa-Kunik, R. Tsruya, E. Schejter, and B.-Z. Shilo Unidirectional Notch signaling depends on continuous cleavage of Delta Development, January 1, 2005; 132(1): 123 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Roy, U. M. Wewer, D. Zurakowski, S. E. Pories, and M. A. Moses ADAM 12 Cleaves Extracellular Matrix Proteins and Correlates with Cancer Status and Stage J. Biol. Chem., December 3, 2004; 279(49): 51323 - 51330. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sundberg, C. K. Thodeti, M. Kveiborg, C. Larsson, P. Parker, R. Albrechtsen, and U. M. Wewer Regulation of ADAM12 Cell-surface Expression by Protein Kinase C {epsilon} J. Biol. Chem., December 3, 2004; 279(49): 51601 - 51611. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kodama, E. Ikeda, A. Okada, T. Ohtsuka, M. Shimoda, T. Shiomi, K. Yoshida, M. Nakada, E. Ohuchi, and Y. Okada ADAM12 Is Selectively Overexpressed in Human Glioblastomas and Is Associated with Glioblastoma Cell Proliferation and Shedding of Heparin-Binding Epidermal Growth Factor Am. J. Pathol., November 1, 2004; 165(5): 1743 - 1753. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Cao, Z. Zhao, J. Gruszczynska-Biegala, and A. Zolkiewska Role of Metalloprotease Disintegrin ADAM12 in Determination of Quiescent Reserve Cells during Myogenic Differentiation In Vitro Mol. Cell. Biol., October 1, 2003; 23(19): 6725 - 6738. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Chesneau, J. D. Becherer, Y. Zheng, H. Erdjument-Bromage, P. Tempst, and C. P. Blobel Catalytic Properties of ADAM19 J. Biol. Chem., June 13, 2003; 278(25): 22331 - 22340. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |